Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy

Journal of Nuclear Medicine

Volumn 40, Issue 12, 1999, Pages 2007-2013

  Ohtsuki, Katsuichi ^a   Sugihara, Hiroki ^a   Kuribayashi, Toshiro ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

123I 15 (p iodophenyl) 3 (R,S) methylpentadecanoic acid; Fatty acid metabolism; Hypertrophic cardiomyopathy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; FATTY ACIDS; FEMALE; HEART SEPTUM; HEART VENTRICLES; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033377918     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha-and beta-methyl-branched fatty acids J Med Chem. 1984;27:390-397.
2. Knapp FF Jr, Anibrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies, Eur J Nucl Med. 1986;12(suppl):S39-S44.
3. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med. 1995;36:1022-1030.
4. Knapp FF Jr, Goldman MM. Ambrose KR, et al. The Development of Radioiodinated 3-Methyl-Branched Fatty Acids for Evaluation of Myocardial Disease by Single Photon Techniques. Dordrecht, The Netherlands: Martinus Nijhoff; 1987; 159-201.
5. Fujibayashi Y, Yonekura Y, Kawai K, et al. Basic studies on I-123-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor [in Japanese]. Kaku Igaka. 1988;25:1131-1135.
6. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med. 1996;37:757-761.
7. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts J Nucl Med. 1995;36:1043-1050.
8. Kurata C, Tawarahara K, Taguchi T, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med. 1992;33:6-13.
9. Shimonagata T, Nishimura T, Uehara T, et al. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy. Nucl Med Commun. 1993;14:1005-1013.
10. 123I-BMIPP). Nucl Med Commun. 1994;15:441-447.
11. Kobayashi H, Nakata T, Han S, et al. Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid [in Japanese]. J Cardiol 1994;24:35-43.
12. Takoishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R.S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med. 1992;19:775-782.
13. 123I-labeled 15-(p-iodophenyll-3-R.S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy [in Japanese]. Kaku Igaku. 1995;32:377-385.
14. Tadamura E, Kudoh T, Hattori M, et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med. 1998;39:390-396.
15. 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPECT. Nucl Med Commun. 1995;16:336-343.
16. 123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography. Ann Nucl Med. 1996;10:71-78
17. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979;43:1242-1244.
18. Maron BJ. Asymmetry in hypertrophic cardiomyopathy: the septal to free wall thickness ratio revisited. Am J Cardiol 1985;55:835-838.
19. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol, 1983;2:437-444.
20. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418-428.
21. Garcia EV, Van Train K, Maddahi J, et al. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med. 1985;26:17-26.
22. Tadamura E, Tamaki N, Matsumori A, et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med. 1996;37:572-577.
23. Kuribayashi T, Roberts WC. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:1333-1340
24. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med. 1995;36:1043-1050.
25. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BM1PP in canine myocardium. J Nucl Med. 1996;37:757-761.